Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 169 citing articles:

Neuropathological evidence of body-first vs. brain-first Lewy body disease
Per Borghammer, Jacob Horsager, Katrine B. Andersen, et al.
Neurobiology of Disease (2021) Vol. 161, pp. 105557-105557
Open Access | Times Cited: 146
Clinical and imaging evidence of brain-first and body-first Parkinson's disease
Jacob Horsager, Karoline Knudsen, Michael Sommerauer
Neurobiology of Disease (2022) Vol. 164, pp. 105626-105626
Open Access | Times Cited: 98
A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson’s disease
Per Borghammer, Mie Kristine Just, Jacob Horsager, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 89
The heterogeneity of Parkinson’s disease
Ullrich Wüllner, Per Borghammer, Chi‐un Choe, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 827-838
Open Access | Times Cited: 67
The brain-first vs. body-first model of Parkinson’s disease with comparison to alternative models
Per Borghammer
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 737-753
Closed Access | Times Cited: 52
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 47
Brain-first vs. body-first Parkinson's disease: An update on recent evidence
Jacob Horsager, Per Borghammer
Parkinsonism & Related Disorders (2024) Vol. 122, pp. 106101-106101
Open Access | Times Cited: 34
Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same
Per Borghammer, Niels Okkels, Daniel Weintraub
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 3, pp. 383-397
Open Access | Times Cited: 17
Inflammatory bowel disease induces pathological α‐synuclein aggregation in the human gut and brain
Ana M. Espinosa‐Oliva, Rocío Ruiz, Manuel Sarmiento Soto, et al.
Neuropathology and Applied Neurobiology (2024) Vol. 50, Iss. 1
Open Access | Times Cited: 16
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology
Sophie E Mastenbroek, Jacob W. Vogel, Lyduine E. Collij, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson’s disease
Christopher E. J. Doppler, Martin Byskov Kinnerup, Corinna Brune, et al.
Brain (2021) Vol. 144, Iss. 9, pp. 2732-2744
Open Access | Times Cited: 74
Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson’s Disease Subtypes
Karoline Knudsen, Tatyana D. Fedorova, Jacob Horsager, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 4, pp. 1677-1687
Closed Access | Times Cited: 59
Locus Coeruleus Integrity from 7 T MRI Relates to Apathy and Cognition in Parkinsonian Disorders
Rong Ye, Claire O’Callaghan, Catarina Rua, et al.
Movement Disorders (2022) Vol. 37, Iss. 8, pp. 1663-1672
Open Access | Times Cited: 49
Current Treatments and New, Tentative Therapies for Parkinson’s Disease
Teresa Pardo-Moreno, Victoria García‐Morales, Nora Suleiman‐Martos, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 770-770
Open Access | Times Cited: 39
Combining skin and olfactory α-synuclein seed amplification assays (SAA)—towards biomarker-driven phenotyping in synucleinopathies
Anastasia Kuzkina, Jonas Rößle, A. Seger, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis
Sven Kleine Bardenhorst, Emanuele Cereda, Marco Severgnini, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 11, pp. 3581-3594
Open Access | Times Cited: 34
Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease
Aron Emmi, Michele Sandre, Francesco Paolo Russo, et al.
Movement Disorders (2023) Vol. 38, Iss. 5, pp. 885-894
Open Access | Times Cited: 29
Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies
Niels Okkels, Jacob Horsager, Miguel A. Labrador‐Espinosa, et al.
Brain (2023) Vol. 146, Iss. 9, pp. 3690-3704
Open Access | Times Cited: 25
A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn (“line 61”) Mice
Franziska Richter, Miloš Stanojlović, Christopher Käufer, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 1, pp. 97-116
Open Access | Times Cited: 23
A topographical atlas of α-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs
Haley Geertsma, Zoe Fisk, Lillian Sauline, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 15
Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes
Niels Okkels, Michel J. Grothe, John‐Paul Taylor, et al.
Brain (2024) Vol. 147, Iss. 7, pp. 2308-2324
Closed Access | Times Cited: 14
Defining Parkinson’s Disease: Past and Future
Kristína Kulcsarová, Matěj Škorvánek, Ronald B. Postuma, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S257-S271
Open Access | Times Cited: 13
Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease
Fabio Casciano, Enrico Zauli, Claudio Celeghini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1689-1689
Open Access | Times Cited: 12
Progression subtypes in Parkinson’s disease identified by a data-driven multi cohort analysis
Tom Hähnel, Tamara Raschka, Stefano Sapienza, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson’s disease
Dhairya A. Lakhani, Xiangzhi Zhou, Shengzhen Tao, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top